Sep 17, 2026, 11:00 UTC
Pulsenmore received MHRA registration allowing its Pulsenmore FC home ultrasound product to be marketed across the United Kingdom and Northern Ireland, expanding its fertility platform into the UK market.
Source:Sep 8, 2026, 11:00 UTC
Pulsenmore Ltd. completed CE European registration of its home ultrasound system for follicular monitoring, expanding into fertility care and the broader women's health market in Europe.
Source:Aug 19, 2026, 11:00 UTC
Pulsenmore announced that its home ultrasound technology will be integrated at Lis Maternity and Women's Hospital at Ichilov in Israel, expanding at-home pregnancy monitoring access.
Source:Aug 17, 2026, 11:00 UTC
The Israel Innovation Authority approved a $1.27 million grant to Pulsenmore for its SmartScan AI program, the second AI grant within a month, bringing total AI grants to approximately $1.6 million.
Source:Jul 13, 2026, 11:00 UTC
Pulsenmore was selected by the Israel Innovation Authority and Ministry of Health to lead a $1 million AI development project.
Source:Jun 25, 2026, 12:00 UTC
Pulsenmore Ltd. priced a $7.5 million private placement of ordinary shares and warrants with a healthcare-focused institutional investor.
Source:Jun 24, 2026, 11:00 UTC
Pulsenmore announced a strategic partnership with Ouma Health to integrate its home ultrasound technology into Ouma Health's virtual maternity care model across the United States.
Source: